Introduction: Black adults in the United States experience a disproportionately higher risk of dementia due to cumulative exposure to structural and social determinants of health (S/SDOH). Although structural neuroimaging provides markers of atrophy and cerebrovascular injury, less is known about how these biomarkers interact with S/SDOH to influence cognitive performance within minoritized populations. This study examined independent and interactive associations between a multidimensional S/SDOH Composite Index (S/SDOH-CI) and structural imaging–derived biomarkers among Black adults in an urban setting. Methods: We analyzed data from a community-based sample of Black adults aged ≥45 who completed brain MRI, the Preclinical Alzheimer Cognitive Composite (PACC), the Montreal Cognitive Assessment (MoCA), and a comprehensive assessment of structural and social determinants of health (S/SDOH). Structural biomarkers included total brain volume, hippocampal volume, global and regional white matter hyperintensities (WMH), and brain-age gap (BAG). Linear regression models examined independent and interactive associations between the S/ S/SDOH-CI and MRI biomarkers with cognitive performance, adjusting for demographic characteristics and Charleston comorbidity index. Results: Total brain volume and BAG were associated with MoCA. Significant interactions were observed between S/SDOH-CI and BAG for cognitive outcomes. Across S/SDOH factors, discrimination, and coping moderated associations between WMH and PACC, while education moderated associations between brain volume and MoCA. Discussion: These findings underscore that the biological vulnerability cannot be fully understood without accounting for structural and social disparities. Differential sensitivity of MRI biomarkers highlights the need for neuroimaging research tailored to diverse populations and supports integrating S/SDOH to inform precision-equity approaches to dementia prevention.
Yiqi Zhu, A. I. Walker, Semere Bekena et al.· Social Science & Medicine (1...· 0 citations
BackgroundHearing impairment (HI) has been identified as a potentially modifiable risk factor for dementia, yet its relationship with Alzheimer's disease (AD) neuropathology and the temporal directionality remain unclear, particularly in late life.ObjectiveTo examine cross-sectional and longitudinal associations between HI, clinical cognitive status, and AD biomarkers in community-dwelling older adults.MethodsWe included 474 DRIVES Project participants (mean age 73.5 ± 5.2 years). Hearing was assessed using the NIH Toolbox Words-in-Noise (WIN) test. Clinical cognitive status was assessed using Clinical Dementia Rating (CDR). AD biomarkers included cerebrospinal fluid (CSF) Aβ42/Aβ40, t-tau/Aβ42, and p-tau/Aβ42 ratios and amyloid PET imaging. Multivariable linear, logistic, Cox proportional hazards, and Fine-Gray competing-risk models were used.ResultsHI was more prevalent among participants with mild cognitive impairment (MCI; defined as CDR = 0.5) than cognitively normal individuals (50% versus 24%, p < 0.001), and MCI status was independently associated with worse baseline WIN thresholds (β = 1.55 dB SNR; 95% CI 0.72-2.37). HI was not cross-sectionally associated with CSF amyloid or tau ratios or amyloid PET positivity. Longitudinally, baseline MCI was associated with a higher risk of incident HI (Cox HR = 2.63, 95% CI 1.48-4.67; Fine-Gray sHR = 2.79, 95% CI 1.06-7.40), whereas baseline HI was not associated with subsequent CDR progression.ConclusionsIn older adults, HI was associated with MCI but not core AD biomarkers or future CDR progression, suggesting that late-life HI may reflect cognitive vulnerability or broader brain aging rather than independently driving AD pathology.
Semere Bekena, R. Singh, Subrata Pal et al.· Journal of Alzheimer's Disea...· 0 citations